Skip to content
BOLUS

Signal from the log

Teal Health

22 M$ · Series A · United States · Diagnostics

Teal Health vend un dispositif de prélèvement que la femme utilise chez elle pour dépister le cancer du col de l'utérus, à la place du frottis au cabinet. Le communiqué du jour nomme le tour de table cinq semaines après le dépôt réglementaire qui l'avait révélé. Le Form D du 13 août donne 21 264 213 dollars réellement placés auprès de 40 investisseurs, première vente le 5 août.

Article

Announced on , logged by the watch of 22 September 2026.

Operation
Funding round
Announced amount
22 M$
Stage
Series A
Country
United States
Sector
Diagnostics

What the log says

Editorial note, in French

Sujet traité. L'article donne les sources et la position de Bolus.

The investors

Led by .406 Ventures , with Emerson Collective , Forerunner , Serena Ventures , MPower Partners

Read the article on this operation (in French)

Provenance
Logged on 22 September 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Article The operation led to an article, with its sources checked one by one.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.

One address, nothing else.

One letter a week, on Fridays: the week's funding rounds, the funds named, the amounts double checked. The list is never sold, one click to unsubscribe. The letter is written in French.

Email confirmation before any subscription. The list is never sold. What Bolus knows about you is written on the privacy page (in French).